Company profile NVAX

Novavax, Inc.
novavax, inc. is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. our recombinant nanoparticles and matrix-m™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. product pipeline our product pipeline targets a variety of inf...ectious diseases with vaccine candidates currently in clinical development for respiratory syncytial virus ("rsv"​), seasonal influenza, pandemic influenza, and ebola virus ("ebov"​). we have additional preclinical-stage programs for a variety of infectious diseases. corporate overview novavax is headquartered in gaithersburg, maryland with additional facilities in rockville, maryland and uppsala, sweden. novavax is traded on the nasdaq stock market under the symbol nvax and employs over 300 individuals dedicated to developing novel vaccines to address infectious disease. Show More
Quarter analysis & expected interestLast update: February 09 2024 18:35:40.

After 39 days of this quarter the interest is at 34.0. Based on that we can calculate that during remaining 52 days it will total up to 79.0.
Novavax expected interest is significantly lower compared to previous quarter (-63.6%) but similar to same quarter last year.

YearQ1Q2Q3Q4
201933
23
-30.3% QoQ
16
-30.4% QoQ
12
-25.0% QoQ
2020 103
212.1% YoY 758.3% QoQ
236
926.1% YoY 129.1% QoQ
489
2956.2% YoY 107.2% QoQ
289
2308.3% YoY -40.9% QoQ
2021 541
425.2% YoY 87.2% QoQ
456
93.2% YoY -15.7% QoQ
588
20.2% YoY 28.9% QoQ
537
85.8% YoY -8.7% QoQ
2022 446
-17.6% YoY -16.9% QoQ
290
-36.4% YoY -35.0% QoQ
353
-40.0% YoY 21.7% QoQ
148
-72.4% YoY -58.1% QoQ
2023 99
-77.8% YoY -33.1% QoQ
69
-76.2% YoY -30.3% QoQ
98
-72.2% YoY 42.0% QoQ
217
46.6% YoY 121.4% QoQ
2024 34
-65.7% YoY -84.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Novavax search interestLast update: February 09 2024 18:35:39.
Correlation coefficient between keyword and revenue is 0.52
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:35:42.

The average 5 years interest of Novavax was 19.45 per week.
The last year interest of Novavax compared to the last 5 years has changed by -53.73%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 345.54%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:36:01.

After 39 days of this quarter the interest is at 58.0. Based on that we can calculate that during remaining 52 days it will total up to 135.0.
Novavax COVID-19 vaccine expected interest is significantly lower compared to previous quarter (-46.2%) but similar to same quarter last year.

YearQ1Q2Q3Q4
201956
79
41.1% QoQ
81
2.5% QoQ
22
-72.8% QoQ
2020 0
-100.0% YoY -100.0% QoQ
108
36.7% YoY inf% QoQ
157
93.8% YoY 45.4% QoQ
126
472.7% YoY -19.7% QoQ
2021 281
inf% YoY 123.0% QoQ
428
296.3% YoY 52.3% QoQ
415
164.3% YoY -3.0% QoQ
227
80.2% YoY -45.3% QoQ
2022 303
7.8% YoY 33.5% QoQ
173
-59.6% YoY -42.9% QoQ
449
8.2% YoY 159.5% QoQ
156
-31.3% YoY -65.3% QoQ
2023 162
-46.5% YoY 3.8% QoQ
69
-60.1% YoY -57.4% QoQ
92
-79.5% YoY 33.3% QoQ
251
60.9% YoY 172.8% QoQ
2024 58
-64.2% YoY -76.9% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Novavax COVID-19 vaccine search interestLast update: February 09 2024 18:36:01.
Correlation coefficient between keyword and revenue is 0.66
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:36:02.

The average 5 years interest of Novavax COVID-19 vaccine was 14.15 per week.
The last year interest of Novavax COVID-19 vaccine compared to the last 5 years has changed by -23.32%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 136.9%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:36:08.

After 39 days of this quarter the interest is at 6.0. Based on that we can calculate that during remaining 52 days it will total up to 14.0.
COVID-19 vaccine expected interest is significantly lower compared to previous quarter (-46.2%) and same quarter last year (-56.2%).

YearQ1Q2Q3Q4
20190
0
0
0
2020 32
inf% YoY inf% QoQ
71
inf% YoY 121.9% QoQ
106
inf% YoY 49.3% QoQ
225
inf% YoY 112.3% QoQ
2021 966
2918.8% YoY 329.3% QoQ
433
509.9% YoY -55.2% QoQ
340
220.8% YoY -21.5% QoQ
216
-4.0% YoY -36.5% QoQ
2022 124
-87.2% YoY -42.6% QoQ
62
-85.7% YoY -50.0% QoQ
58
-82.9% YoY -6.5% QoQ
49
-77.3% YoY -15.5% QoQ
2023 32
-74.2% YoY -34.7% QoQ
24
-61.3% YoY -25.0% QoQ
29
-50.0% YoY 20.8% QoQ
26
-46.9% YoY -10.3% QoQ
2024 6
-81.2% YoY -76.9% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and COVID-19 vaccine search interestLast update: February 09 2024 18:36:07.
Correlation coefficient between keyword and revenue is 0.33
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:36:09.

The average 5 years interest of COVID-19 vaccine was 10.72 per week.
The last year interest of COVID-19 vaccine compared to the last 5 years has changed by -82.28%.
This is something to be checked.
This didn't exist 5 years ago.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:36:15.

After 39 days of this quarter the interest is at 62.0. Based on that we can calculate that during remaining 52 days it will total up to 145.0.
Covovax expected interest is significantly higher compared to previous quarter (+1015.4%) and same quarter last year (+107.1%).

YearQ1Q2Q3Q4
20190
62
inf% QoQ
0
-100.0% QoQ
22
inf% QoQ
2020 167
inf% YoY 659.1% QoQ
95
53.2% YoY -43.1% QoQ
66
inf% YoY -30.5% QoQ
52
136.4% YoY -21.2% QoQ
2021 226
35.3% YoY 334.6% QoQ
154
62.1% YoY -31.9% QoQ
110
66.7% YoY -28.6% QoQ
338
550.0% YoY 207.3% QoQ
2022 264
16.8% YoY -21.9% QoQ
84
-45.5% YoY -68.2% QoQ
70
-36.4% YoY -16.7% QoQ
211
-37.6% YoY 201.4% QoQ
2023 70
-73.5% YoY -66.8% QoQ
13
-84.5% YoY -81.4% QoQ
51
-27.1% YoY 292.3% QoQ
13
-93.8% YoY -74.5% QoQ
2024 62
-11.4% YoY 376.9% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Covovax search interestLast update: February 09 2024 18:36:14.
Correlation coefficient between keyword and revenue is 0.39
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:36:16.

The average 5 years interest of Covovax was 8.16 per week.
The last year interest of Covovax compared to the last 5 years has changed by -67.28%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by -4.3%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:36:21.

After 39 days of this quarter the interest is at 16.0. Based on that we can calculate that during remaining 52 days it will total up to 37.0.
Nuvaxovid expected interest is significantly lower compared to previous quarter (-83.5%) and same quarter last year (-43.9%).

YearQ1Q2Q3Q4
201930
42
40.0% QoQ
0
-100.0% QoQ
107
inf% QoQ
2020 43
43.3% YoY -59.8% QoQ
99
135.7% YoY 130.2% QoQ
109
inf% YoY 10.1% QoQ
99
-7.5% YoY -9.2% QoQ
2021 66
53.5% YoY -33.3% QoQ
95
-4.0% YoY 43.9% QoQ
62
-43.1% YoY -34.7% QoQ
121
22.2% YoY 95.2% QoQ
2022 265
301.5% YoY 119.0% QoQ
266
180.0% YoY 0.4% QoQ
223
259.7% YoY -16.2% QoQ
91
-24.8% YoY -59.2% QoQ
2023 66
-75.1% YoY -27.5% QoQ
93
-65.0% YoY 40.9% QoQ
47
-78.9% YoY -49.5% QoQ
224
146.2% YoY 376.6% QoQ
2024 16
-75.8% YoY -92.9% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Nuvaxovid search interestLast update: February 09 2024 18:36:21.
Correlation coefficient between keyword and revenue is 0.66
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:36:23.

The average 5 years interest of Nuvaxovid was 8.29 per week.
The last year interest of Nuvaxovid compared to the last 5 years has changed by -0.97%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 120.11%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Matrix-M adjuvant to provide analysis

Correlation between past revenue and Matrix-M adjuvant search interest

There is not enough data for Matrix-M adjuvant to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Matrix-M adjuvant to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:36:29.

After 39 days of this quarter the interest is at 191.0. Based on that we can calculate that during remaining 52 days it will total up to 446.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019272
297
9.2% QoQ
496
67.0% QoQ
628
26.6% QoQ
2020 679
149.6% YoY 8.1% QoQ
468
57.6% YoY -31.1% QoQ
710
43.1% YoY 51.7% QoQ
795
26.6% YoY 12.0% QoQ
2021 558
-17.8% YoY -29.8% QoQ
454
-3.0% YoY -18.6% QoQ
753
6.1% YoY 65.9% QoQ
784
-1.4% YoY 4.1% QoQ
2022 528
-5.4% YoY -32.7% QoQ
422
-7.0% YoY -20.1% QoQ
551
-26.8% YoY 30.6% QoQ
805
2.7% YoY 46.1% QoQ
2023 467
-11.6% YoY -42.0% QoQ
419
-0.7% YoY -10.3% QoQ
537
-2.5% YoY 28.2% QoQ
740
-8.1% YoY 37.8% QoQ
2024 191
-59.1% YoY -74.2% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and influenza vaccine search interestLast update: February 09 2024 18:36:29.
Correlation coefficient between keyword and revenue is 0.14
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:36:31.

The average 5 years interest of influenza vaccine was 44.27 per week.
The last year interest of influenza vaccine compared to the last 5 years has changed by -7.39%.
The interest for influenza vaccine is seasonal.
The last year interest is comparable to 5 years ago. It has changed only by 10.36%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:36:36.

After 39 days of this quarter the interest is at 58.0. Based on that we can calculate that during remaining 52 days it will total up to 135.0.
respiratory syncytial virus vaccine expected interest is significantly higher compared to same quarter last year (+170.0%) but similar to previous quarter.

YearQ1Q2Q3Q4
201954
93
72.2% QoQ
22
-76.3% QoQ
43
95.5% QoQ
2020 33
-38.9% YoY -23.3% QoQ
10
-89.2% YoY -69.7% QoQ
75
240.9% YoY 650.0% QoQ
61
41.9% YoY -18.7% QoQ
2021 78
136.4% YoY 27.9% QoQ
83
730.0% YoY 6.4% QoQ
19
-74.7% YoY -77.1% QoQ
61
0.0% YoY 221.1% QoQ
2022 54
-30.8% YoY -11.5% QoQ
114
37.3% YoY 111.1% QoQ
42
121.1% YoY -63.2% QoQ
105
72.1% YoY 150.0% QoQ
2023 50
-7.4% YoY -52.4% QoQ
217
90.4% YoY 334.0% QoQ
130
209.5% YoY -40.1% QoQ
209
99.0% YoY 60.8% QoQ
2024 58
16.0% YoY -72.2% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and respiratory syncytial virus vaccine search interestLast update: February 09 2024 18:36:36.
Correlation coefficient between keyword and revenue is 0.27
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:36:37.

The average 5 years interest of respiratory syncytial virus vaccine was 6.17 per week.
The last year interest of respiratory syncytial virus vaccine compared to the last 5 years has changed by 103.89%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 208.33%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:36:43.

After 39 days of this quarter the interest is at 45.0. Based on that we can calculate that during remaining 52 days it will total up to 105.0.
malaria vaccine expected interest is significantly higher compared to same quarter last year (+47.9%) but similar to previous quarter.

YearQ1Q2Q3Q4
201944
98
122.7% QoQ
61
-37.8% QoQ
59
-3.3% QoQ
2020 257
484.1% YoY 335.6% QoQ
114
16.3% YoY -55.6% QoQ
45
-26.2% YoY -60.5% QoQ
48
-18.6% YoY 6.7% QoQ
2021 58
-77.4% YoY 20.8% QoQ
83
-27.2% YoY 43.1% QoQ
62
37.8% YoY -25.3% QoQ
187
289.6% YoY 201.6% QoQ
2022 69
19.0% YoY -63.1% QoQ
83
0.0% YoY 20.3% QoQ
66
6.5% YoY -20.5% QoQ
70
-62.6% YoY 6.1% QoQ
2023 71
2.9% YoY 1.4% QoQ
132
59.0% YoY 85.9% QoQ
119
80.3% YoY -9.8% QoQ
99
41.4% YoY -16.8% QoQ
2024 45
-36.6% YoY -54.5% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and malaria vaccine search interestLast update: February 09 2024 18:36:43.
Correlation coefficient between keyword and revenue is -0.17
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:36:44.

The average 5 years interest of malaria vaccine was 7.16 per week.
The last year interest of malaria vaccine compared to the last 5 years has changed by 15.78%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 52.95%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for NVAX
Earnings date: 2024-02-27 After close
Company name: Novavax, Inc.
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-11T11:53:49+0000

CNBC
Hantavirus cases spark surge in pharma and biotech stocks — here’s why

2026-05-07T16:00:00-04:00

PR Newswire
Novavax to Participate in BofA Securities 2026 Health Care Conference

2026-05-06T19:42:27Z

Analyst Upgrades
TD Cowen Maintains Hold on Novavax, Raises Price Target to $9

2026-05-06T08:00:00-04:00

PR Newswire
Novavax Reports First Quarter 2026 Financial Results and Operational Highlights

2026-04-29T16:00:00-04:00

PR Newswire
Novavax to Report First Quarter 2026 Financial Results on May 6, 2026

2026-03-30T08:00:00-04:00

PR Newswire
Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development

2026-02-27T11:40:50Z

Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Novavax, Raises Price Target to $16

2026-02-26T16:30:00-05:00

PR Newswire
Novavax to Participate in Upcoming Investor Conferences

2026-02-26T08:00:00-05:00

PR Newswire
Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

2026-02-19T08:00:00-05:00

PR Newswire
Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

2026-01-20T07:15:00-05:00

PR Newswire
Novavax Announces Entering into a License Agreement with Pfizer

2026-01-07T08:00:00-05:00

PR Newswire
Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

2025-11-12T21:46:37Z

Reuters
Shah Capital pushes for Novavax sale, warns of proxy fight

2025-11-12T08:00:00-05:00

PR Newswire
Novavax to Participate in Jefferies London Healthcare Conference

2025-11-10T15:27:16Z

Analyst Upgrades
B. Riley Securities Reiterates Buy on Novavax, Lowers Price Target to $16